Hims & Hers Health, Inc.

Fundamentals3.5
Price Action4.0
News Sentiment4.0
AI Rating
4.0

Key Drivers

  • Gross Margin
  • Cash Burn
  • Leverage Spike

AI
AI Summary

4.0

Hims is shifting from a pure growth story to a capital-efficiency test: despite strong revenue momentum, falling gross margins, cash burn, rising leverage, and the FTC lawsuit mean investors should wait for proof that growth can continue without destroying profitability or balance-sheet flexibility.

ExecutionRisk
Legal
CashBurn

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

3.5

Key Financial Insights:

  • Gross Margin
  • Cash Burn
  • Leverage Spike

HIMS still has strong gross economics, but the latest quarter showed a sharp swing to losses, cash burn, higher leverage, and weaker liquidity, making execution the key risk despite modest sales/book valuation.

MixedResults
BalanceSheetRisk

Price Behavior

4.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Lower highs
  • Failed breakout
  • Range support

HIMS has trended lower over the last month, with a strong early-August rebound fading into lower highs and weaker closes, so caution is warranted unless it reclaims the low-30s .

caution
rangebound
Support Level: $27.0 to $28.0
Resistance Level: $31.5 to $32.2

Sharp rebound from 2026-07-29 to 2026-08-04, then momentum faded

Sentiment & News

4.0

Key News Insights:

  • Revenue lift
  • Margin pressure
  • Legal scrutiny

Hims & Hers is drawing bullish growth interest from stronger revenue guidance, AI-driven engagement and GLP-1 tailwinds, but ongoing margin pressure and repeated securities investigations keep legal risk elevated.

Growth
Risk

The headlines are supportive for long-term growth, but near-term sentiment may stay volatile until profitability and investigation risks become clearer